SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-132157
Filing Date
2020-12-03
Accepted
2020-12-03 21:42:14
Documents
1
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2037705d9_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2037705d9_4seq1.xml 4 12800
  Complete submission text file 0001104659-20-132157.txt   14412
Mailing Address C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH SAN FRANCISCO CA 94158
Business Address
Gergel Ivan P. (Reporting) CIK: 0001328288 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 201368607

Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations